img

Global Coagulation Factor IX Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Coagulation Factor IX Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1.
The global Coagulation Factor IX market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Coagulation Factor IX is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The China market for Coagulation Factor IX is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The Europe market for Coagulation Factor IX is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034..
The global key manufacturers of Coagulation Factor IX include Pfizer, CSL Behring, Grifols, Novo Nordisk, Bioverativ, Sanquin, Takeda, Baxter and Aptevo, etc. In 2024, the global top five players hold a share approximately % in sales volume, and in term of revenue of Coagulation Factor IX, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Coagulation Factor IX by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global Coagulation Factor IX market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Coagulation Factor IX market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Pfizer
CSL Behring
Grifols
Novo Nordisk
Bioverativ
Sanquin
Takeda
Baxter
Aptevo
By Type
Coagulation Factor IX (Plasma Derived)
Coagulation Factor IX (Recombinant)
By Application
Adult
Kids
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Coagulation Factor IX in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Coagulation Factor IX manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Coagulation Factor IX sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Coagulation Factor IX Definition
1.2 Market by Type
1.2.1 Global Coagulation Factor IX Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Coagulation Factor IX (Plasma Derived)
1.2.3 Coagulation Factor IX (Recombinant)
1.3 Market Segment by Application
1.3.1 Global Coagulation Factor IX Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Adult
1.3.3 Kids
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Coagulation Factor IX Sales
2.1 Global Coagulation Factor IX Revenue Estimates and Forecasts 2018-2034
2.2 Global Coagulation Factor IX Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Coagulation Factor IX Revenue by Region
2.3.1 Global Coagulation Factor IX Revenue by Region (2018-2023)
2.3.2 Global Coagulation Factor IX Revenue by Region (2024-2034)
2.4 Global Coagulation Factor IX Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Coagulation Factor IX Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Coagulation Factor IX Sales Quantity by Region
2.6.1 Global Coagulation Factor IX Sales Quantity by Region (2018-2023)
2.6.2 Global Coagulation Factor IX Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Coagulation Factor IX Sales Quantity by Manufacturers
3.1.1 Global Coagulation Factor IX Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Coagulation Factor IX Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Coagulation Factor IX Sales in 2024
3.2 Global Coagulation Factor IX Revenue by Manufacturers
3.2.1 Global Coagulation Factor IX Revenue by Manufacturers (2018-2023)
3.2.2 Global Coagulation Factor IX Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Coagulation Factor IX Revenue in 2024
3.3 Global Coagulation Factor IX Sales Price by Manufacturers
3.4 Global Key Players of Coagulation Factor IX, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Coagulation Factor IX, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Coagulation Factor IX, Product Offered and Application
3.8 Global Key Manufacturers of Coagulation Factor IX, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Coagulation Factor IX Sales Quantity by Type
4.1.1 Global Coagulation Factor IX Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Coagulation Factor IX Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Coagulation Factor IX Sales Quantity Market Share by Type (2018-2034)
4.2 Global Coagulation Factor IX Revenue by Type
4.2.1 Global Coagulation Factor IX Historical Revenue by Type (2018-2023)
4.2.2 Global Coagulation Factor IX Forecasted Revenue by Type (2024-2034)
4.2.3 Global Coagulation Factor IX Revenue Market Share by Type (2018-2034)
4.3 Global Coagulation Factor IX Price by Type
4.3.1 Global Coagulation Factor IX Price by Type (2018-2023)
4.3.2 Global Coagulation Factor IX Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Coagulation Factor IX Sales Quantity by Application
5.1.1 Global Coagulation Factor IX Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Coagulation Factor IX Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Coagulation Factor IX Sales Quantity Market Share by Application (2018-2034)
5.2 Global Coagulation Factor IX Revenue by Application
5.2.1 Global Coagulation Factor IX Historical Revenue by Application (2018-2023)
5.2.2 Global Coagulation Factor IX Forecasted Revenue by Application (2024-2034)
5.2.3 Global Coagulation Factor IX Revenue Market Share by Application (2018-2034)
5.3 Global Coagulation Factor IX Price by Application
5.3.1 Global Coagulation Factor IX Price by Application (2018-2023)
5.3.2 Global Coagulation Factor IX Price Forecast by Application (2024-2034)
6 North America
6.1 North America Coagulation Factor IX Sales by Company
6.1.1 North America Coagulation Factor IX Revenue by Company (2018-2023)
6.1.2 North America Coagulation Factor IX Sales Quantity by Company (2018-2023)
6.2 North America Coagulation Factor IX Market Size by Type
6.2.1 North America Coagulation Factor IX Sales Quantity by Type (2018-2034)
6.2.2 North America Coagulation Factor IX Revenue by Type (2018-2034)
6.3 North America Coagulation Factor IX Market Size by Application
6.3.1 North America Coagulation Factor IX Sales Quantity by Application (2018-2034)
6.3.2 North America Coagulation Factor IX Revenue by Application (2018-2034)
6.4 North America Coagulation Factor IX Market Size by Country
6.4.1 North America Coagulation Factor IX Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Coagulation Factor IX Revenue by Country (2018-2034)
6.4.3 North America Coagulation Factor IX Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Coagulation Factor IX Sales by Company
7.1.1 Europe Coagulation Factor IX Sales Quantity by Company (2018-2023)
7.1.2 Europe Coagulation Factor IX Revenue by Company (2018-2023)
7.2 Europe Coagulation Factor IX Market Size by Type
7.2.1 Europe Coagulation Factor IX Sales Quantity by Type (2018-2034)
7.2.2 Europe Coagulation Factor IX Revenue by Type (2018-2034)
7.3 Europe Coagulation Factor IX Market Size by Application
7.3.1 Europe Coagulation Factor IX Sales Quantity by Application (2018-2034)
7.3.2 Europe Coagulation Factor IX Revenue by Application (2018-2034)
7.4 Europe Coagulation Factor IX Market Size by Country
7.4.1 Europe Coagulation Factor IX Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Coagulation Factor IX Revenue by Country (2018-2034)
7.4.3 Europe Coagulation Factor IX Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Coagulation Factor IX Sales by Company
8.1.1 China Coagulation Factor IX Sales Quantity by Company (2018-2023)
8.1.2 China Coagulation Factor IX Revenue by Company (2018-2023)
8.2 China Coagulation Factor IX Market Size by Type
8.2.1 China Coagulation Factor IX Sales Quantity by Type (2018-2034)
8.2.2 China Coagulation Factor IX Revenue by Type (2018-2034)
8.3 China Coagulation Factor IX Market Size by Application
8.3.1 China Coagulation Factor IX Sales Quantity by Application (2018-2034)
8.3.2 China Coagulation Factor IX Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Coagulation Factor IX Sales by Company
9.1.1 APAC Coagulation Factor IX Sales Quantity by Company (2018-2023)
9.1.2 APAC Coagulation Factor IX Revenue by Company (2018-2023)
9.2 APAC Coagulation Factor IX Market Size by Type
9.2.1 APAC Coagulation Factor IX Sales Quantity by Type (2018-2034)
9.2.2 APAC Coagulation Factor IX Revenue by Type (2018-2034)
9.3 APAC Coagulation Factor IX Market Size by Application
9.3.1 APAC Coagulation Factor IX Sales Quantity by Application (2018-2034)
9.3.2 APAC Coagulation Factor IX Revenue by Application (2018-2034)
9.4 APAC Coagulation Factor IX Market Size by Region
9.4.1 APAC Coagulation Factor IX Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Coagulation Factor IX Revenue by Region (2018-2034)
9.4.3 APAC Coagulation Factor IX Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Coagulation Factor IX Sales by Company
10.1.1 Middle East, Africa and Latin America Coagulation Factor IX Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Coagulation Factor IX Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Coagulation Factor IX Market Size by Type
10.2.1 Middle East, Africa and Latin America Coagulation Factor IX Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Coagulation Factor IX Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Coagulation Factor IX Market Size by Application
10.3.1 Middle East, Africa and Latin America Coagulation Factor IX Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Coagulation Factor IX Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Coagulation Factor IX Market Size by Country
10.4.1 Middle East, Africa and Latin America Coagulation Factor IX Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Coagulation Factor IX Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Coagulation Factor IX Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Coagulation Factor IX Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Pfizer Coagulation Factor IX Products and Services
11.1.5 Pfizer Coagulation Factor IX SWOT Analysis
11.1.6 Pfizer Recent Developments
11.2 CSL Behring
11.2.1 CSL Behring Company Information
11.2.2 CSL Behring Overview
11.2.3 CSL Behring Coagulation Factor IX Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 CSL Behring Coagulation Factor IX Products and Services
11.2.5 CSL Behring Coagulation Factor IX SWOT Analysis
11.2.6 CSL Behring Recent Developments
11.3 Grifols
11.3.1 Grifols Company Information
11.3.2 Grifols Overview
11.3.3 Grifols Coagulation Factor IX Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Grifols Coagulation Factor IX Products and Services
11.3.5 Grifols Coagulation Factor IX SWOT Analysis
11.3.6 Grifols Recent Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Information
11.4.2 Novo Nordisk Overview
11.4.3 Novo Nordisk Coagulation Factor IX Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Novo Nordisk Coagulation Factor IX Products and Services
11.4.5 Novo Nordisk Coagulation Factor IX SWOT Analysis
11.4.6 Novo Nordisk Recent Developments
11.5 Bioverativ
11.5.1 Bioverativ Company Information
11.5.2 Bioverativ Overview
11.5.3 Bioverativ Coagulation Factor IX Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Bioverativ Coagulation Factor IX Products and Services
11.5.5 Bioverativ Coagulation Factor IX SWOT Analysis
11.5.6 Bioverativ Recent Developments
11.6 Sanquin
11.6.1 Sanquin Company Information
11.6.2 Sanquin Overview
11.6.3 Sanquin Coagulation Factor IX Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Sanquin Coagulation Factor IX Products and Services
11.6.5 Sanquin Coagulation Factor IX SWOT Analysis
11.6.6 Sanquin Recent Developments
11.7 Takeda
11.7.1 Takeda Company Information
11.7.2 Takeda Overview
11.7.3 Takeda Coagulation Factor IX Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Takeda Coagulation Factor IX Products and Services
11.7.5 Takeda Coagulation Factor IX SWOT Analysis
11.7.6 Takeda Recent Developments
11.8 Baxter
11.8.1 Baxter Company Information
11.8.2 Baxter Overview
11.8.3 Baxter Coagulation Factor IX Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Baxter Coagulation Factor IX Products and Services
11.8.5 Baxter Coagulation Factor IX SWOT Analysis
11.8.6 Baxter Recent Developments
11.9 Aptevo
11.9.1 Aptevo Company Information
11.9.2 Aptevo Overview
11.9.3 Aptevo Coagulation Factor IX Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Aptevo Coagulation Factor IX Products and Services
11.9.5 Aptevo Coagulation Factor IX SWOT Analysis
11.9.6 Aptevo Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Coagulation Factor IX Value Chain Analysis
12.2 Coagulation Factor IX Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Coagulation Factor IX Production Mode & Process
12.4 Coagulation Factor IX Sales and Marketing
12.4.1 Coagulation Factor IX Sales Channels
12.4.2 Coagulation Factor IX Distributors
12.5 Coagulation Factor IX Customers
13 Market Dynamics
13.1 Coagulation Factor IX Industry Trends
13.2 Coagulation Factor IX Market Drivers
13.3 Coagulation Factor IX Market Challenges
13.4 Coagulation Factor IX Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Coagulation Factor IX Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Coagulation Factor IX (Plasma Derived)
Table 3. Major Manufacturers of Coagulation Factor IX (Recombinant)
Table 4. Global Coagulation Factor IX Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 5. Global Coagulation Factor IX Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Coagulation Factor IX Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Coagulation Factor IX Revenue Market Share by Region (2018-2023)
Table 8. Global Coagulation Factor IX Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Coagulation Factor IX Revenue Market Share by Region (2024-2034)
Table 10. Global Coagulation Factor IX Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 11. Global Coagulation Factor IX Sales by Region (2018-2023) & (K Units)
Table 12. Global Coagulation Factor IX Sales Market Share by Region (2018-2023)
Table 13. Global Coagulation Factor IX Sales by Region (2024-2034) & (K Units)
Table 14. Global Coagulation Factor IX Sales Market Share by Region (2024-2034)
Table 15. Global Coagulation Factor IX Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 16. Global Coagulation Factor IX Sales Quantity Share by Manufacturers (2018-2023)
Table 17. Global Coagulation Factor IX Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Coagulation Factor IX Revenue Share by Manufacturers (2018-2023)
Table 19. Global Coagulation Factor IX Price by Manufacturers 2018-2023 (USD/Unit)
Table 20. Global Key Players of Coagulation Factor IX, Industry Ranking, 2021 VS 2024
Table 21. Global Coagulation Factor IX Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Coagulation Factor IX by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Coagulation Factor IX as of 2024)
Table 23. Global Key Manufacturers of Coagulation Factor IX, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Coagulation Factor IX, Product Offered and Application
Table 25. Global Key Manufacturers of Coagulation Factor IX, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Coagulation Factor IX Sales Quantity by Type (2018-2023) & (K Units)
Table 28. Global Coagulation Factor IX Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global Coagulation Factor IX Sales Quantity Share by Type (2018-2023)
Table 30. Global Coagulation Factor IX Sales Quantity Share by Type (2024-2034)
Table 31. Global Coagulation Factor IX Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Coagulation Factor IX Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Coagulation Factor IX Revenue Share by Type (2018-2023)
Table 34. Global Coagulation Factor IX Revenue Share by Type (2024-2034)
Table 35. Coagulation Factor IX Price by Type (2018-2023) & (USD/Unit)
Table 36. Global Coagulation Factor IX Price Forecast by Type (2024-2034) & (USD/Unit)
Table 37. Global Coagulation Factor IX Sales Quantity by Application (2018-2023) & (K Units)
Table 38. Global Coagulation Factor IX Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global Coagulation Factor IX Sales Quantity Share by Application (2018-2023)
Table 40. Global Coagulation Factor IX Sales Quantity Share by Application (2024-2034)
Table 41. Global Coagulation Factor IX Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Coagulation Factor IX Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Coagulation Factor IX Revenue Share by Application (2018-2023)
Table 44. Global Coagulation Factor IX Revenue Share by Application (2024-2034)
Table 45. Coagulation Factor IX Price by Application (2018-2023) & (USD/Unit)
Table 46. Global Coagulation Factor IX Price Forecast by Application (2024-2034) & (USD/Unit)
Table 47. North America Coagulation Factor IX Revenue by Company (2018-2023) & (US$ Million)
Table 48. North America Coagulation Factor IX Sales Quantity by Company (2018-2023) & (K Units)
Table 49. North America Coagulation Factor IX Sales Quantity by Type (2018-2023) & (K Units)
Table 50. North America Coagulation Factor IX Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America Coagulation Factor IX Revenue by Type (2018-2023) & (US$ Million)
Table 52. North America Coagulation Factor IX Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Coagulation Factor IX Sales Quantity by Application (2018-2023) & (K Units)
Table 54. North America Coagulation Factor IX Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America Coagulation Factor IX Revenue by Application (2018-2023) & (US$ Million)
Table 56. North America Coagulation Factor IX Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Coagulation Factor IX Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 58. North America Coagulation Factor IX Revenue by Country (2018-2023) & (US$ Million)
Table 59. North America Coagulation Factor IX Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Coagulation Factor IX Sales Quantity by Country (2018-2023) & (K Units)
Table 61. North America Coagulation Factor IX Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe Coagulation Factor IX Sales Quantity by Company (2018-2023) & (K Units)
Table 63. Europe Coagulation Factor IX Revenue by Company (2018-2023) & (US$ Million)
Table 64. Europe Coagulation Factor IX Sales Quantity by Type (2018-2023) & (K Units)
Table 65. Europe Coagulation Factor IX Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe Coagulation Factor IX Revenue by Type (2018-2023) & (US$ Million)
Table 67. Europe Coagulation Factor IX Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Coagulation Factor IX Sales Quantity by Application (2018-2023) & (K Units)
Table 69. Europe Coagulation Factor IX Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe Coagulation Factor IX Revenue by Application (2018-2023) & (US$ Million)
Table 71. Europe Coagulation Factor IX Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Coagulation Factor IX Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 73. Europe Coagulation Factor IX Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Coagulation Factor IX Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Coagulation Factor IX Sales Quantity by Country (2018-2023) & (K Units)
Table 76. Europe Coagulation Factor IX Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China Coagulation Factor IX Sales Quantity by Company (2018-2023) & (K Units)
Table 78. China Coagulation Factor IX Revenue by Company (2018-2023) & (US$ Million)
Table 79. China Coagulation Factor IX Sales Quantity by Type (2018-2023) & (K Units)
Table 80. China Coagulation Factor IX Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China Coagulation Factor IX Revenue by Type (2018-2023) & (US$ Million)
Table 82. China Coagulation Factor IX Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Coagulation Factor IX Sales Quantity by Application (2018-2023) & (K Units)
Table 84. China Coagulation Factor IX Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China Coagulation Factor IX Revenue by Application (2018-2023) & (US$ Million)
Table 86. China Coagulation Factor IX Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Coagulation Factor IX Sales Quantity by Company (2018-2023) & (K Units)
Table 88. APAC Coagulation Factor IX Revenue by Company (2018-2023) & (US$ Million)
Table 89. APAC Coagulation Factor IX Sales Quantity by Type (2018-2023) & (K Units)
Table 90. APAC Coagulation Factor IX Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC Coagulation Factor IX Revenue by Type (2018-2023) & (US$ Million)
Table 92. APAC Coagulation Factor IX Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Coagulation Factor IX Sales Quantity by Application (2018-2023) & (K Units)
Table 94. APAC Coagulation Factor IX Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC Coagulation Factor IX Revenue by Application (2018-2023) & (US$ Million)
Table 96. APAC Coagulation Factor IX Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Coagulation Factor IX Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 98. APAC Coagulation Factor IX Revenue by Region (2018-2023) & (US$ Million)
Table 99. APAC Coagulation Factor IX Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Coagulation Factor IX Sales Quantity by Region (2018-2023) & (K Units)
Table 101. APAC Coagulation Factor IX Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Coagulation Factor IX Sales Quantity by Company (2018-2023) & (K Units)
Table 103. Middle East, Africa and Latin America Coagulation Factor IX Revenue by Company (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Coagulation Factor IX Sales Quantity by Type (2018-2023) & (K Units)
Table 105. Middle East, Africa and Latin America Coagulation Factor IX Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Coagulation Factor IX Revenue by Type (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Coagulation Factor IX Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Coagulation Factor IX Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Middle East, Africa and Latin America Coagulation Factor IX Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Coagulation Factor IX Revenue by Application (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America Coagulation Factor IX Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Coagulation Factor IX Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Coagulation Factor IX Revenue by Country (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Coagulation Factor IX Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Coagulation Factor IX Sales Quantity by Country (2018-2023) & (K Units)
Table 116. Middle East, Africa and Latin America Coagulation Factor IX Sales Quantity by Country (2024-2034) & (K Units)
Table 117. Pfizer Company Information
Table 118. Pfizer Description and Overview
Table 119. Pfizer Coagulation Factor IX Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 120. Pfizer Coagulation Factor IX Product and Services
Table 121. Pfizer Coagulation Factor IX SWOT Analysis
Table 122. Pfizer Recent Developments
Table 123. CSL Behring Company Information
Table 124. CSL Behring Description and Overview
Table 125. CSL Behring Coagulation Factor IX Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 126. CSL Behring Coagulation Factor IX Product and Services
Table 127. CSL Behring Coagulation Factor IX SWOT Analysis
Table 128. CSL Behring Recent Developments
Table 129. Grifols Company Information
Table 130. Grifols Description and Overview
Table 131. Grifols Coagulation Factor IX Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 132. Grifols Coagulation Factor IX Product and Services
Table 133. Grifols Coagulation Factor IX SWOT Analysis
Table 134. Grifols Recent Developments
Table 135. Novo Nordisk Company Information
Table 136. Novo Nordisk Description and Overview
Table 137. Novo Nordisk Coagulation Factor IX Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 138. Novo Nordisk Coagulation Factor IX Product and Services
Table 139. Novo Nordisk Coagulation Factor IX SWOT Analysis
Table 140. Novo Nordisk Recent Developments
Table 141. Bioverativ Company Information
Table 142. Bioverativ Description and Overview
Table 143. Bioverativ Coagulation Factor IX Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 144. Bioverativ Coagulation Factor IX Product and Services
Table 145. Bioverativ Coagulation Factor IX SWOT Analysis
Table 146. Bioverativ Recent Developments
Table 147. Sanquin Company Information
Table 148. Sanquin Description and Overview
Table 149. Sanquin Coagulation Factor IX Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 150. Sanquin Coagulation Factor IX Product and Services
Table 151. Sanquin Coagulation Factor IX SWOT Analysis
Table 152. Sanquin Recent Developments
Table 153. Takeda Company Information
Table 154. Takeda Description and Overview
Table 155. Takeda Coagulation Factor IX Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 156. Takeda Coagulation Factor IX Product and Services
Table 157. Takeda Coagulation Factor IX SWOT Analysis
Table 158. Takeda Recent Developments
Table 159. Baxter Company Information
Table 160. Baxter Description and Overview
Table 161. Baxter Coagulation Factor IX Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 162. Baxter Coagulation Factor IX Product and Services
Table 163. Baxter Coagulation Factor IX SWOT Analysis
Table 164. Baxter Recent Developments
Table 165. Aptevo Company Information
Table 166. Aptevo Description and Overview
Table 167. Aptevo Coagulation Factor IX Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2023)
Table 168. Aptevo Coagulation Factor IX Product and Services
Table 169. Aptevo Coagulation Factor IX SWOT Analysis
Table 170. Aptevo Recent Developments
Table 171. Key Raw Materials Lists
Table 172. Raw Materials Key Suppliers Lists
Table 173. Coagulation Factor IX Distributors List
Table 174. Coagulation Factor IX Customers List
Table 175. Coagulation Factor IX Market Trends
Table 176. Coagulation Factor IX Market Drivers
Table 177. Coagulation Factor IX Market Challenges
Table 178. Coagulation Factor IX Market Restraints
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Coagulation Factor IX Product Picture
Figure 2. Global Coagulation Factor IX Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Coagulation Factor IX Market Share by Type in 2024 & 2034
Figure 4. Coagulation Factor IX (Plasma Derived) Product Picture
Figure 5. Coagulation Factor IX (Recombinant) Product Picture
Figure 6. Global Coagulation Factor IX Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 7. Global Coagulation Factor IX Market Share by Application in 2024 & 2034
Figure 8. Adult
Figure 9. Kids
Figure 10. Coagulation Factor IX Report Years Considered
Figure 11. Global Coagulation Factor IX Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Coagulation Factor IX Revenue 2018-2034 (US$ Million)
Figure 13. Global Coagulation Factor IX Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 14. Global Coagulation Factor IX Sales Quantity 2018-2034 (K Units)
Figure 15. Global Coagulation Factor IX Sales Quantity Market Share by Region (2018-2023)
Figure 16. Global Coagulation Factor IX Sales Quantity Market Share by Region (2024-2034)
Figure 17. North America Coagulation Factor IX Sales Quantity YoY (2018-2034) & (K Units)
Figure 18. North America Coagulation Factor IX Revenue YoY (2018-2034) & (US$ Million)
Figure 19. Europe Coagulation Factor IX Sales Quantity YoY (2018-2034) & (K Units)
Figure 20. Europe Coagulation Factor IX Revenue YoY (2018-2034) & (US$ Million)
Figure 21. China Coagulation Factor IX Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. China Coagulation Factor IX Revenue YoY (2018-2034) & (US$ Million)
Figure 23. APAC Coagulation Factor IX Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. APAC Coagulation Factor IX Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Coagulation Factor IX Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. Middle East, Africa and Latin America Coagulation Factor IX Revenue YoY (2018-2034) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Coagulation Factor IX Sales Quantity in 2024
Figure 28. The Top 10 and Top 5 Players Market Share by Coagulation Factor IX Revenue in 2024
Figure 29. Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 30. Global Coagulation Factor IX Sales Quantity Market Share by Type (2018-2034)
Figure 31. Global Coagulation Factor IX Revenue Market Share by Type (2018-2034)
Figure 32. Global Coagulation Factor IX Sales Quantity Market Share by Application (2018-2034)
Figure 33. Global Coagulation Factor IX Revenue Market Share by Application (2018-2034)
Figure 34. North America Coagulation Factor IX Revenue Market Share by Company in 2024
Figure 35. North America Coagulation Factor IX Sales Quantity Market Share by Company in 2024
Figure 36. North America Coagulation Factor IX Sales Quantity Market Share by Type (2018-2034)
Figure 37. North America Coagulation Factor IX Revenue Market Share by Type (2018-2034)
Figure 38. North America Coagulation Factor IX Sales Quantity Market Share by Application (2018-2034)
Figure 39. North America Coagulation Factor IX Revenue Market Share by Application (2018-2034)
Figure 40. North America Coagulation Factor IX Revenue Share by Country (2018-2034)
Figure 41. North America Coagulation Factor IX Sales Quantity Share by Country (2018-2034)
Figure 42. U.S. Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 43. Canada Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 44. Europe Coagulation Factor IX Sales Quantity Market Share by Company in 2024
Figure 45. Europe Coagulation Factor IX Revenue Market Share by Company in 2024
Figure 46. Europe Coagulation Factor IX Sales Quantity Market Share by Type (2018-2034)
Figure 47. Europe Coagulation Factor IX Revenue Market Share by Type (2018-2034)
Figure 48. Europe Coagulation Factor IX Sales Quantity Market Share by Application (2018-2034)
Figure 49. Europe Coagulation Factor IX Revenue Market Share by Application (2018-2034)
Figure 50. Europe Coagulation Factor IX Revenue Share by Country (2018-2034)
Figure 51. Europe Coagulation Factor IX Sales Quantity Share by Country (2018-2034)
Figure 52. Germany Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 53. France Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 54. U.K. Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 55. Italy Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 56. Russia Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 57. China Coagulation Factor IX Sales Quantity Market Share by Company in 2024
Figure 58. China Coagulation Factor IX Revenue Market Share by Company in 2024
Figure 59. China Coagulation Factor IX Sales Quantity Market Share by Type (2018-2034)
Figure 60. China Coagulation Factor IX Revenue Market Share by Type (2018-2034)
Figure 61. China Coagulation Factor IX Sales Quantity Market Share by Application (2018-2034)
Figure 62. China Coagulation Factor IX Revenue Market Share by Application (2018-2034)
Figure 63. APAC Coagulation Factor IX Sales Quantity Market Share by Company in 2024
Figure 64. APAC Coagulation Factor IX Revenue Market Share by Company in 2024
Figure 65. APAC Coagulation Factor IX Sales Quantity Market Share by Type (2018-2034)
Figure 66. APAC Coagulation Factor IX Revenue Market Share by Type (2018-2034)
Figure 67. APAC Coagulation Factor IX Sales Quantity Market Share by Application (2018-2034)
Figure 68. APAC Coagulation Factor IX Revenue Market Share by Application (2018-2034)
Figure 69. APAC Coagulation Factor IX Revenue Share by Region (2018-2034)
Figure 70. APAC Coagulation Factor IX Sales Quantity Share by Region (2018-2034)
Figure 71. Japan Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 72. South Korea Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 73. China Taiwan Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 75. India Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 76. Middle East, Africa and Latin America Coagulation Factor IX Sales Quantity Market Share by Company in 2024
Figure 77. Middle East, Africa and Latin America Coagulation Factor IX Revenue Market Share by Company in 2024
Figure 78. Middle East, Africa and Latin America Coagulation Factor IX Sales Quantity Market Share by Type (2018-2034)
Figure 79. Middle East, Africa and Latin America Coagulation Factor IX Revenue Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Coagulation Factor IX Sales Quantity Market Share by Application (2018-2034)
Figure 81. Middle East, Africa and Latin America Coagulation Factor IX Revenue Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Coagulation Factor IX Sales Quantity Share by Country (2018-2034)
Figure 83. Middle East, Africa and Latin America Coagulation Factor IX Revenue Share by Country (2018-2034)
Figure 84. Brazil Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 85. Mexico Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 86. Turkey Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 87. Israel Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 88. GCC Countries Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 89. Coagulation Factor IX Value Chain
Figure 90. Coagulation Factor IX Production Process
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries